Jolkinolide B induces cell cycle arrest and apoptosis in MKN45 gastric cancer cells and inhibits xenograft tumor growth in vivo

• Published in: Bioscience reports Vol. 42; no. 6; p. 1
• Main Authors: Zhang, Hao, Qian, Jiayi, Jin, Ming, Fan, Li, Fan, SongJie, Pan, Hong, Li, Yang, Wang, Ningning, Jian, Baiyu
• Format: Journal Article
• Language: English
• Published: England Portland Press Ltd The Biochemical Society 01.06.2022; Portland Press Ltd
• Subjects: Animals; Antibodies; Antitumor activity; Apoptosis; Biotechnology; Cancer; Cell cycle; Cell Cycle Checkpoints; Cell Cycle, Growth & Proliferation; Cell Death & Injury; Cell growth; Cell Line, Tumor; Cell Proliferation; Chinese medicine; CHK1 protein; Diterpenes; Diterpenes - pharmacology; Diterpenes - therapeutic use; DNA damage; Flow cytometry; Gastric cancer; Herbal medicine; Heterografts; Humans; In vivo methods and tests; Medical research; Membranes; Mice; Mice, Nude; Natural products; Poisons; Poisons - pharmacology; Proteins; R&D; Research & development; Signal transduction; Stomach Neoplasms - drug therapy; Traditional Chinese medicine; Tumors; Variance analysis; Xenografts; Xenotransplantation; China; Cell Cycle; Jolkinolide B; Apoptosis
• ISSN: 0144-8463; 1573-4935; 1573-4935
• DOI: 10.1042/BSR20220341

Gastric cancer is one of the most common digestive carcinomas throughout the world and represents high mortality. There is an urgent quest for seeking a novel and efficient antigastric cancer drug. Euphorbia fischeriana Steud had long been used as a traditional Chinese medicine for the treatment of cancer. According to the basic theory of traditional Chinese medicine, its antitumor mechanism is 'to combat poison with poison'. However, its effective material foundation of it is still ambiguous. In our previous work, we studied the chemical constituents of E. fischeriana Steud. Jolkinolide B (JB) is an ent-abietane-type diterpenoid we isolated from it. The purpose of the present study was to investigate the antigastric effect and mechanism of JB. Results revealed that JB could suppress the proliferation of MKN45 cells in vitro and inhibit MKN45 xenograft tumor growth in nude mice in vivo. We further investigated its anticancer mechanism. On the one hand, JB caused DNA damage in gastric cancer MKN45 cells and induced the S cycle arrest by activating the ATR-CHK1-CDC25A-Cdk2 signaling pathway, On the other hand, JB induced MKN45 cells apoptosis through the mitochondrial pathway, and ultimately effectively inhibited the growth of gastric cancer cells. These results suggest that JB appears to be a promising candidate drug with antigastric cancer activity and warrants further research.